-The Times of India PABNAWA (HARYANA): It has been over 48 hours since the attack took place. But fear still stalks the dalits of Pabnawa village in Haryana's Kaithal district. The young women from the community have been moved out en masse by their families fearing sexual assault by upper-caste goons. Some were picked up by relatives from nearby villages after desperate SOS calls; others were escorted to safety by their...

-The Economic Times The government's plan to make the Aadhaar number the centrepiece of the cash-transfer system is now facing opposition from a new quarter: banks. Several banks, led by the State Bank of India, have expressed reservation against jettisoning their current systems in favour of the platform created by the Unique Identification Authority of India (UIDAI), which issues the Aadhaar number and wants to make it the basis to authenticate...

-The Hindu     Focus attention on pregnancy and first two years of child's life Stunting can be contained by focussing attention on pregnancy and the first two years of a child's life, a new UNICEF report has said. Stunting is not only about a child being too short for his or her age. It can also mean suffering from stunted development of the brain and cognitive capacity. The report offers evidence that real progress is...

-The Hindu     Enhancing the basket of contraceptive choices can reduce maternal mortality rate, says a family planning review Family planning has made a silent comeback in the national discourses. This time, focussing more on concomitant improvement in the health of the people rather than limiting the number of children. India had changed its strategy on family planning in 2010 with the other developing countries from that of merely reducing population to that of...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...